PRCT
PROCEPT BioRobotics Corporation
$25.40
-0.16%
2026-05-08
About PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. The company also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Key Fundamentals
Forward P/E
-28.35
EPS (TTM)
$-1.83
ROE
-27.8%
Revenue Growth (YoY)
20.2%
Profit Margin
-31.8%
Debt/Equity
22.43
Price/Book
4.09
Beta
0.83
Market Cap
$1.42B
Avg Volume (10D)
1.6M
Recent Breakout Signals
No recent breakout signals detected for PRCT.
Recent Price Range (60 Days)
60D High
$29.57
60D Low
$19.35
Avg Volume
1.6M
Latest Close
$25.40
Get breakout alerts for PRCT
Sign up for Breakout Scanner to receive daily notifications when PRCT triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
PROCEPT BioRobotics Corporation (PRCT) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PRCT daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PRCT operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.